Home Outcomes of pregnancies at high-risk for placenta accreta spectrum following negative diagnostic imaging
Article
Licensed
Unlicensed Requires Authentication

Outcomes of pregnancies at high-risk for placenta accreta spectrum following negative diagnostic imaging

  • Callie F. Reeder ORCID logo EMAIL logo , Kendra R. Sylvester-Armstrong , Lauren M. Silva , Erika M. Wert , John C. Smulian and Mehmet R. Genc
Published/Copyright: February 25, 2022

Abstract

Objectives

To assess the pretest and negative post-test probability for placenta accreta spectrum (PAS) in a group of patients with high-risk clinical factors.

Methods

We included patients with suspected and/or confirmed PAS at our institution over 8 years. Sonography performed by maternal-fetal medicine specialists, and selected patients underwent MRI. Imaging was considered positive if either sonography or MRI suggested PAS. Histopathology was the gold standard for diagnosis of PAS. We assessed the pretest and negative imaging-test probability, and resources required.

Results

We identified 82 high-risk patients with the following: (1) a history of ≥1 cesarean section and/or intrauterine gynecologic procedure and placenta previa in the index pregnancy; (2) a history of >3 cesarean deliveries and/or gynecologic procedures regardless of placental location; (3) prior PAS disorder, or retained placenta requiring manual extraction and/or curettage, complicated by postpartum hemorrhage; and (4) suspected cesarean section scar pregnancy. Histopathology confirmed PAS in 52 patients, with pretest probability of 63%. Imaging correctly identified 44/50 cases with PAS, and excluded this condition in 24/30 cases. Thus, the positive and negative post-test probability for PAS following negative imaging was 88 and 20%, respectively. Of the six patients with false-negative imaging, all had either surgical complications or required care beyond that for routine cesarean section.

Conclusions

Although diagnostic imaging is sensitive, the negative posttest probability remains high in women with high pretest probability for PAS. Therefore, women at high risk for PAS should be managed in experienced centers by a multidisciplinary team even if imaging is negative.


Corresponding author: Callie F. Reeder, MD, Department of Obstetrics and Gynecology, University of Florida College of Medicine, P.O. Box 100294 Gainesville, FL 32610, USA, Phone: +352 273 9706, E-mail:

Acknowledgments

The PAS team at University of Florida.

  1. Research funding: None declared.

  2. Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  3. Competing interests: Authors state no conflict of interest.

  4. Informed consent: Not applicable.

  5. Ethical approval: The research related to human use has complied with all the relevant national regulations, institutional policies, and in accordance with the tenets of the Helsinki Declaration, and has been approved by the authors’ Institutional Review Board or equivalent committee. (University of Florida IRB, 201801557).

References

1. Jauniaux, E, Bunce, C, Gronbeck, L, Langhoff-Roos, J. Prevalence, and main outcomes of placenta accreta spectrum: a systematic review and meta-analysis. Am J Obstet Gynecol 2019;221:208–18. https://doi.org/10.1016/j.ajog.2019.01.233.Search in Google Scholar PubMed

2. Bowman, ZS, Eller, AG, Kennedy, AM, Richards, DS, Winter, TC, Woodward, PJ, et al.. Accuracy of ultrasound for the prediction of placenta accreta. Am J Obstet Gynecol 2014;211:177 e1–7. https://doi.org/10.1016/j.ajog.2014.03.029.Search in Google Scholar PubMed

3. Baldwin, HJ, Patterson, JA, Nippita, TA, Torvaldsen, S, Ibiebele, I, Simpson, JM, et al.. Antecedents of abnormally invasive placenta in primiparous women: risk associated with gynecologic procedures. Obstet Gynecol 2018;131:227–33. https://doi.org/10.1097/aog.0000000000002434.Search in Google Scholar

4. Silver, RM, Landon, MB, Rouse, DJ, Leveno, KJ, Spong, CY, Thom, EA, et al.. Maternal morbidity associated with multiple repeat cesarean deliveries. Obstet Gynecol 2006;107:1226–32. https://doi.org/10.1097/01.aog.0000219750.79480.84.Search in Google Scholar PubMed

5. Fitzpatrick, KE, Sellers, S, Spark, P, Kurinczuk, JJ, Brocklehurst, P, Knight, M. Incidence and risk factors for placenta accreta/increta/percreta in the U.K.: a national case-control study. PLoS One 2012;7:e52893. https://doi.org/10.1371/journal.pone.0052893.Search in Google Scholar PubMed PubMed Central

6. Sentilhes, L, Kayem, G, Ambroselli, C, Provansal, M, Fernandez, H, Perrotin, F, et al.. Fertility and pregnancy outcomes following conservative treatment for placenta accreta. Hum Reprod 2010;25:2803–10. https://doi.org/10.1093/humrep/deq239.Search in Google Scholar PubMed PubMed Central

7. Eshkoli, T, Weintraub, AY, Sergienko, R, Sheiner, E. Placenta accreta: risk factors, perinatal outcomes, and consequences for subsequent births. Am J Obstet Gynecol 2013;208:219 e1–7. https://doi.org/10.1016/j.ajog.2012.12.037.Search in Google Scholar PubMed

8. Cali, G, Timor-Tritsch, IE, Palacios-Jaraquemada, J, Monteaugudo, A, Buca, D, Forlani, F, et al.. Outcome of Cesarean scar pregnancy managed expectantly: systematic review and meta-analysis. Ultrasound Obstet Gynecol 2018;51:169–75. https://doi.org/10.1002/uog.17568.Search in Google Scholar PubMed

9. D’Antonio, F, Iacovella, C, Bhide, A. Prenatal identification of invasive placentation using ultrasound: systematic review and meta-analysis. Ultrasound Obstet Gynecol 2013;42:509–17. https://doi.org/10.1002/uog.13194.Search in Google Scholar PubMed

10. Einerson, BD, Rodriguez, CE, Kennedy, AM, Woodward, PJ, Donnelly, MA, Silver, RM. Magnetic resonance imaging is often misleading when used as an adjunct to ultrasound in the management of placenta accreta spectrum disorders. Am J Obstet Gynecol 2018;218:618 e1–7. https://doi.org/10.1016/j.ajog.2018.03.013.Search in Google Scholar PubMed

11. Menard, MK, Main, EK, Currigan, SM. Executive summary of the reVITALize initiative: standardizing obstetric data definitions. Obstet Gynecol 2014;124:150–3. https://doi.org/10.1097/aog.0000000000000322.Search in Google Scholar PubMed

12. D’Antonio, F, Iacovella, C, Palacios-Jaraquemada, J, Bruno, CH, Manzoli, L, Bhide, A. Prenatal identification of invasive placentation using magnetic resonance imaging: systematic review and meta-analysis. Ultrasound Obstet Gynecol 2014;44:8–16. https://doi.org/10.1002/uog.13327.Search in Google Scholar PubMed

13. Smulian, JC, Pascual, AL, Hesham, H, Qureshey, E, Bijoy Thomas, M, Depuy, AM, et al.. Invasive placental disease: the impact of a multidisciplinary team approach to management. J Matern Fetal Neonatal Med 2017;30:1423–7. https://doi.org/10.1080/14767058.2016.1216099.Search in Google Scholar PubMed

14. Yasin, N, Slade, L, Atkinson, E, Kennedy-Andrews, S, Scroggs, S, Grivell, R. The multidisciplinary management of placenta accreta spectrum (PAS) within a single tertiary centre: a ten-year experience. Aust N Z J Obstet Gynaecol 2019;59:550–4. https://doi.org/10.1111/ajo.12932.Search in Google Scholar PubMed

15. Erfani, H, Fox, KA, Clark, SL, Rac, M, Rocky Hui, SK, Rezaei, A, et al.. Maternal outcomes in unexpected placenta accreta spectrum disorders: single-center experience with a multidisciplinary team. Am J Obstet Gynecol 2019;221:337 e1–5. https://doi.org/10.1016/j.ajog.2019.05.035.Search in Google Scholar PubMed PubMed Central

16. Tinari, S, Buca, D, Cali, G, Timor-Tritsch, I, Palacios-Jaraquemada, J, Rizzo, G, et al.. Systematic review and meta-analysis of posterior placenta accreta spectrum disorders: risk factors, histopathology and diagnostic accuracy. Ultrasound Obstet Gynecol 2020. https://doi.org/10.1002/uog.22183 [Epub ahead of print].Search in Google Scholar PubMed

Received: 2021-11-10
Accepted: 2022-02-07
Published Online: 2022-02-25
Published in Print: 2022-06-27

© 2022 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Reviews
  3. Venous thrombosis risk factors in pregnant women
  4. Ethical considerations of maternal-fetal surgery
  5. Opinion Paper
  6. John Stuart Mill is relevant to COVID-19 vaccination in pregnancy today
  7. Corner of Academy
  8. Excellent perinatal outcome of monoamniotic twin pregnancy with timely diagnosis and optimal management – a retrospective cohort study
  9. Original Articles – Obstetrics
  10. Giving birth alone due to COVID-19-related hospital restrictions compared to accompanied birth: psychological distress in women with caesarean section or vaginal birth – a cross-sectional study
  11. COVID-19 and its effect on Instagram adoption by #OBGYN residency programs
  12. The role of the placenta in spontaneous preterm labor and delivery with intact membranes
  13. New ultrasonographic midtrimester scoring method for predicting spontaneous preterm birth in uncomplicated asymptomatic twin pregnancies
  14. Antenatal corticosteroids and neonatal outcomes in preterm birth in the United States
  15. Pregnancy, delivery, and neonatal outcomes among women with psoriatic arthritis, a population based study
  16. Maternal and neonatal outcomes among pregnant women with inflammatory myopathies
  17. Outcomes of pregnancies at high-risk for placenta accreta spectrum following negative diagnostic imaging
  18. Risk factors for postpartum hemorrhage in patients with retained placenta: building a predict model
  19. Prediction of insulin therapy in women with gestational diabetes: a systematic review and meta-analysis of observational studies
  20. Timing of delivery in antenatal fetal hydronephrosis: a snap shot social media survery of obstetric and fetal medicine practice
  21. Original Article – Neonates
  22. Is low cerebral near infrared spectroscopy oximetry associated with neurodevelopment of preterm infants without brain injury?
  23. Short Communication
  24. Postpartum depression, mode of delivery, and indication for unscheduled cesarean delivery: a retrospective cohort study
  25. Letters to the Editor
  26. Peripartum cephalocenthesis in a large fetal hydranencephaly
  27. John Stuart Mill and COVID-19 vaccination
  28. Letter reply “John Stuart Mill and COVID-19 vaccination”
Downloaded on 16.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jpm-2021-0591/html
Scroll to top button